Literature DB >> 30796186

Targeting CXCR4-induced desmoplasia to improve checkpoint inhibition in breast cancer.

George W Sledge1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30796186      PMCID： PMC6421464          DOI： 10.1073/pnas.1900368116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  4 in total

1.  Increased Survival by Pulmonary Treatment of Established Lung Metastases with Dual STAT3/CXCR4 Inhibition by siRNA Nanoemulsions.

Authors:  Zhaoting Li; Gang Chen; Ling Ding; Yixin Wang; Chenfei Zhu; Kaikai Wang; Jing Li; Minjie Sun; David Oupicky
Journal:  Mol Ther       Date:  2019-08-22       Impact factor: 11.454

Review 2.  Targeting cancer stem cells in drug discovery: Current state and future perspectives.

Authors:  Fang-Yu Du; Qi-Fan Zhou; Wen-Jiao Sun; Guo-Liang Chen
Journal:  World J Stem Cells       Date:  2019-07-26       Impact factor: 5.326

Review 3.  The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases.

Authors:  Shahid Hussain; Bo Peng; Mathew Cherian; Jonathan W Song; Dinesh K Ahirwar; Ramesh K Ganju
Journal:  Front Immunol       Date:  2020-12-22       Impact factor: 7.561

Review 4.  The biological role of the CXCL12/CXCR4 axis in esophageal squamous cell carcinoma.

Authors:  Xianxian Wu; Hongdian Zhang; Zhilin Sui; Yang Wang; Zhentao Yu
Journal:  Cancer Biol Med       Date:  2021-03-12       Impact factor: 4.248
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.